280 related articles for article (PubMed ID: 30827505)
1. MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7.
Zhu H; Xiao X; Chai Y; Li D; Yan X; Tang H
Biochem Biophys Res Commun; 2019 Apr; 511(3):671-678. PubMed ID: 30827505
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
[TBL] [Abstract][Full Text] [Related]
3. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1.
Zhou Q; Yang L; Larson S; Basra S; Merwat S; Tan A; Croce C; Verne GN
Gut; 2016 May; 65(5):797-805. PubMed ID: 25681400
[TBL] [Abstract][Full Text] [Related]
4. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
[TBL] [Abstract][Full Text] [Related]
5. Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome.
Li ZY; Mao YQ; Hua Q; Sun YH; Wang HY; Ye XG; Hu JX; Wang YJ; Jiang M
World J Gastroenterol; 2024 Mar; 30(10):1431-1449. PubMed ID: 38596485
[TBL] [Abstract][Full Text] [Related]
6. NGF/PI3K/TRPV1 pathway mediates the regulation of visceral pain by acupuncture at "Shangjuxu" (ST37) in irritable bowel syndrome rats with chronic visceral hyperalgesia.
Chen CY; Yu Z; Ji F; He LL; Wang X; Xu B
Zhen Ci Yan Jiu; 2023 Oct; 48(10):1017-1024. PubMed ID: 37879952
[TBL] [Abstract][Full Text] [Related]
7. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1.
Zhu H; Xiao X; Shi Y; Wu Y; Huang Y; Li D; Xiong F; He G; Chai Y; Tang H
Exp Ther Med; 2020 Dec; 20(6):155. PubMed ID: 33093893
[TBL] [Abstract][Full Text] [Related]
9. Colonic overexpression of the T-type calcium channel Ca
Scanzi J; Accarie A; Muller E; Pereira B; Aissouni Y; Goutte M; Joubert-Zakeyh J; Picard E; Boudieu L; Mallet C; Gelot A; Ardid D; Carvalho FA; Dapoigny M
Neurogastroenterol Motil; 2016 Nov; 28(11):1632-1640. PubMed ID: 27196538
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome.
Cui XF; Zhou WM; Yang Y; Zhou J; Li XL; Lin L; Zhang HJ
World J Gastroenterol; 2014 Oct; 20(37):13521-9. PubMed ID: 25309082
[TBL] [Abstract][Full Text] [Related]
11. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E
Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
[TBL] [Abstract][Full Text] [Related]
13. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects of electroacupuncture at ST25 and CV12 in a rat model of postinflammatory irritable bowel syndrome visceral pain.
Zhu X; Liu Z; Qin Y; Niu W; Wang Q; Li L; Zhou J
Acupunct Med; 2018 Aug; 36(4):240-246. PubMed ID: 29720377
[TBL] [Abstract][Full Text] [Related]
15. Multispecies probiotic protects gut barrier function in experimental models.
Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats.
Hou Q; Huang Y; Zhang C; Zhu S; Li P; Chen X; Hou Z; Liu F
J Neurogastroenterol Motil; 2018 Oct; 24(4):656-668. PubMed ID: 30347941
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang.
Chao G; Wang Y; Ye F; Zhang S
Yonsei Med J; 2018 Oct; 59(8):945-950. PubMed ID: 30187701
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.
Zhou Q; Souba WW; Croce CM; Verne GN
Gut; 2010 Jun; 59(6):775-84. PubMed ID: 19951903
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
